Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody.

Zaninelli S, Cattaneo I, Valgardsdottir R, Frapolli R, Bello E, Meroni M, Gianatti A, Panna S, Rizzo P, Tomasoni S, D'Incalci M, Introna M, Golay J, Rambaldi A.

Open source

DOI: 10.1007/s00262-025-04149-2
Published: 2025-09-13
Container: Cancer Immunol Immunother
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00262-025-04149-2,
  title = {Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody.},
  author = {Zaninelli S and  Cattaneo I and  Valgardsdottir R and  Frapolli R and  Bello E and  Meroni M and  Gianatti A and  Panna S and  Rizzo P and  Tomasoni S and  D'Incalci M and  Introna M and  Golay J and  Rambaldi A.},
  year = {2025},
  journal = {Cancer Immunol Immunother},
  doi = {10.1007/s00262-025-04149-2},
  url = {https://doi.org/10.1007/s00262-025-04149-2}
}

RIS

TY  - JOUR
TI  - Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody.
AU  - Zaninelli S
AU  -  Cattaneo I
AU  -  Valgardsdottir R
AU  -  Frapolli R
AU  -  Bello E
AU  -  Meroni M
AU  -  Gianatti A
AU  -  Panna S
AU  -  Rizzo P
AU  -  Tomasoni S
AU  -  D'Incalci M
AU  -  Introna M
AU  -  Golay J
AU  -  Rambaldi A.
PY  - 2025
JO  - Cancer Immunol Immunother
DO  - 10.1007/s00262-025-04149-2
UR  - https://doi.org/10.1007/s00262-025-04149-2
ER  -

APA

S, Z., I, C., R, V., R, F., E, B., M, M., A, G., S, P., P, R., S, T., M, D., M, I., J, G., & A., R. (2025). Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody.. Cancer Immunol Immunother. https://doi.org/10.1007/s00262-025-04149-2

Source records

europe-pmc · retrieved 2026-09-27T13:15:21.183Z
doaj · retrieved 2026-09-27T13:15:21.168Z